HF
INMB icon

HRT Financial’s INmune Bio INMB Stock Holding History

HRT Financial’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137K Buy
+84,358
New +$117K ﹤0.01% 3525
2024
Q2 		– Sell
-29,898
Closed -$351K – 2619
2024
Q1 		$351K Buy
+29,898
New +$361K ﹤0.01% 1461
2021
Q2 		– Sell
-22,055
Closed -$262K – 3157
2021
Q1 		$262K Buy
+22,055
New +$397K ﹤0.01% 2179

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial's INMB Position: Q2 2026 in Review

HRT Financial opened a new position in INmune Bio (INMB) in Q2 2026: 84,358 shares worth $137K. The stake represents ﹤0.01% of the portfolio and ranks #3525 among its holdings. This is a return to the name: HRT Financial previously reported a position in INMB as recently as Q1 2024.

HRT Financial first reported a position in INMB in Q1 2021 and has held it in 3 quarters since. The position peaked at $351K in Q1 2024. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • HRT Financial held 84,358 shares of INmune Bio worth $137K as of Q2 2026.
  • INmune Bio was a new HRT Financial position in Q2 2026.
  • INmune Bio made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3525 holding.
  • HRT Financial first reported a position in INmune Bio in Q1 2021 and has held it in 3 quarters since.
  • HRT Financial's INmune Bio position peaked at $351K in Q1 2024.
  • 83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.